Maplight Therapeutics, Inc. · NASDAQ:MPLT

Kroeger Christopher A. sold 147,639 Maplight Therapeutics, Inc. shares (Form 4)

Traded Jul 15 to Jul 17, 2026 · Filed Jul 17, 2026

From Jul 15 to Jul 17, 2026, Kroeger Christopher A. (Director, Chief Executive Officer) sold 147,639 Maplight Therapeutics, Inc. shares at an average US$36.87 for US$5.44M, leaving 1,246,455 shares. Filed Jul 17, 2026 (Form 4).

Sold
147,639 shares
Price
US$36.87 average (US$36.00 to US$37.96)
Value
US$5.44M
Holding after
1,246,455 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Voting Common StockSale18,950US$36.001,375,144Direct
Jul 15, 2026Voting Common StockSale42,738US$36.991,332,406Direct
Jul 15, 2026Voting Common StockSale90US$37.541,332,316Direct
Jul 16, 2026Voting Common StockSale40,899US$36.461,291,417Direct
Jul 16, 2026Voting Common StockSale28,091US$37.261,263,326Direct
Jul 16, 2026Voting Common StockSale92US$37.961,263,234Direct
Jul 17, 2026Voting Common StockSale16,779US$37.901,246,455Direct

Source

View original at SEC

Related